Sputum, Gotta Love The Stuff!

Size: px
Start display at page:

Download "Sputum, Gotta Love The Stuff!"

Transcription

1 Sputum, Gotta Love The Stuff! Douglas S. Gardenhire, EdD, RRT-NPS, FAARC Associate Professor and Chairman Department of Respiratory Therapy Georgia State University

2 Objectives Differentiate mucus from sputum. Discuss factors associated with abnormal mucus production. Discuss diseases associated with abnormal mucus production. Discuss mucoactive agents. Discuss mucoactive treatments.

3 Overview What is mucus doing for me? Source Factors associated with mucus Mucus and disease vs. Sputum Physical Properties Mucoactive Agents Mucoactive Treatments

4 Mucociliary Escalator Major Defense mechanism Failure Obstruction Thickened adhesive secretions Slowed with disease

5 Mucus.Where and Why Airways Gastrointestinal tract Genital tract Protective Lubricating Waterproofing

6 Source of Airway Secretions Mucus Gel Layer Moved by cilia towards larynx Sol Layer Watery layer below gel layer Produced by Surface epithelial cells Goblet cells Submucosal glands

7 From Gardenhire, D. (2016). Rau s Respiratory Care Pharmacology, Elsevier

8 From Gardenhire, D. (2016). Rau s Respiratory Care Pharmacology, Elsevier

9 Surface Epithelial Cells Surface of Trachea/bronchi Ciliated cells Goblet cells More than 6000 goblet cells per square mm of airway Responds only to irritants Submucosal Glands Produces most of mucus in airway Parasympathetic control Cholinergic Stimulation Possible Sympathetic Innervation

10 From Gardenhire, D. (2016). Rau s Respiratory Care Pharmacology, Elsevier

11 Factors Affecting Mucociliary Transport COPD CF Dry airway (dry gas from MV) Narcotics Suctioning; Trach Cigarette smoke Pollutants Hyperoxia and Hypoxia

12 Food Intake and Mucus Production Does milk or dairy increase mucus? NO No reason to withhold milk from patients with colds, RTI, or chronic disease Pinnock CB, etal Am Rev Respir Dis 141:352, 1990

13 Composition of Mucus 95% water 5% protein

14 Mucus and Disease Chronic Bronchitis Asthma Bronchorrhea Plastic Brochitis Cystic Fibrosis

15 Rogers D, Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007;52(9):1181

16 Chronic Bronchitis Clinically, daily X 3 mon; X 2yrs Hyperplasia goblet cells Goblet cells increase in number Submucosal glands hypertrophy Tobacco smoke; # 1 irritation factor Cause; mucus hypersecretion Associated with rapid decline in lung function Rubin BK, etal. Clin Pulm Med 5:1, 1998; Vestbo J, etal Am J Respir Crit Care Med 153:1530, 1996.

17 Asthma Hypersecretion can occur during exacerbation 80% of all patient report increased sputum Beta agonists on board- Problem? Beta agonists cause hypersecreation IV/Continuous nebulization Fatality? Turner-Warwick M. etal. Postgrad Med J 63(suppl 1):79, Rubin BK, Pediatr Pulmonol Suppl 23:88, Webber SE, etal. Agents Actions 22:82, 1987.

18 Bronchorrhea Clinically 100 ml of watery sputum daily Occurs in about 9% of asthmatics Treat with corticosteroids and/or antibiotics Shimura S, etal. Chest 94:1211, 1988; Marom ZM, etal. J Allergy Clin Immunol 87:1050, 1991.

19 Plastic Bronchitis Rare, Clinically, rigid airway casts Patients may cough up casts of the TB Tree May be toothpaste or pudding-like Madsen P, Shah SA, Rubin BK: Paediatr Respir Rev 6:292, 2005.

20 Cystic Fibrosis Chronic hereditary disease Impaired function of CFTR protein Chronic airway infection with Pseudomonas and other gram bacteria Chronic airway inflammation NO hypersecretion of airway Very little to no mucus in sputum Airway filled with PUS Similar sputum to bronchiectasis Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK: Chest 129:118, 2006.

21 Physical Properties of Mucus Mucus (low viscosity, high elasticity ) Sputum (viscosity increases) From Gardenhire, D. (2016)Rau s Respiratoy Care Pharmacology, Elsevier

22 Mucoactive Agents

23 N-ACETYL L-CYSTEINE (NAC) Reduce hepatic injury with acetaminophen overdose Long history of use No evidence of clinical efficacy Inhaled NAC can cause bronchospasm Breaks down mucus, not sputum Difference between mucus & sputum Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R et al.: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial, Lancet 365 (9470): , 2005.

24 Rogers D, Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007;52(9):1181

25 Dornase Alfa (Pulmozyme) Reduces DNA and F-actin polymers Shak s, etal Proc Natl Acad Sci USA 98:9188, 1990 No efficacy in acute exacerbations No efficacy in non-cf bronchietasis Wilmott RW, etal Am J Respir Crit Care Med 153:1914, 1996 May decrease effectiveness of aminoglycosides Ramsey BW, etal Pediatr Pulmonol 17:404, 1994

26 Courtesy Bruce K. Rubin, From Gardenhire D, (2016) Rau s Respiratory Care Pharmacology, Elsevier

27 Expectorants

28 Iodide Containing Agents Supersaturated Potassium Iodide (SSKI) Stimulate airway fluid secretion Has failed to makes changes to PFT or sputum Rubin B, etal Chest 109:348, 1996

29 Sodium Bicarbonate Tracheal instillation or Inhalation 2% concentration Increases bronchial ph Breaks bonds, decreasing viscosity and elasticity Not clinically shown to increase mucus clearance From Gardenhire D, (2008) Rau s Respiratory Care Pharmacology, Mosby

30 Guaifenesin Can be toxic to cilia if directly applied Works by stimulation of submucosal gland Increases mucus production Not been demonstrated to be effective, clinically Rubin BK, etal. Chest 116:195, 1999

31 Mucus Why Protective Lubricating Waterproofing

32 Oligosaccharides Oligosaccharides side chains make up 80% of mucus Aerosolized low wt molecular heparin Used in treatment of asthma Interferes with antigen-receptor binding Disrupting H+ bond Same thought for use of aerosolized mannitol and dextran Ahmed T, etal. N Engl J Med 329:90, 1993

33

34 Mucokinetics

35 Bronchodilators Beta-agonists Produce mucus, can cause problems Mucus trapping, fatal asthma Work best by increasing airflow Newhouse, MT Euro J Respir Dis Suppl 124:151, 1983

36 Other

37 Hyperosmolar Saline 6% saline increased CF patients PFT Shown to improve PFTs in CF and non-cf bronchiectasis patients. Daviskas E. etal. Respirology 10:46, 2005 Mannitol has been effective in non-cf bronchiectasis patients Wills P, etal. Cochrane Database Syst Rev 3: CD001506, 2006 Not as effective as dornase alfa in CF Suri R, etal. Lancet 358:1316, 2001 Due to cough induction, aerosolized antibiotic therapy must be last!

38 Hypertonic Saline 7% hypertonic solution Commonly used in CF Believed to increase FEV1 by decreasing mucus Pulmosal FDA-cleared, buffered with sodium bicarbonate to a ph of 7.4. Others are acidic ph of 4.5 to 7.0 Pseudomonas aeruginosa has an affinity to colonize in an acidic ph of ~6.0.

39 PulmoSal vs. Hypertonic Saline

40 Mucoactive Therapy

41 Physiotherapy and Breathing Gravity Best if added to conventional CPT Mucus blanket can resist gravity alone GERD is a major problem Thomas J, etal. Am J Respir Crit Care Med 151:846, 1995 Breathing techniques Active cycle breathing (ACB) Diaphragmatic breathing with deep breaths Forced expiratory technique (FET) Huff cough with glottis open Hansani A, etal. Chest 105:1420, 1994 Exercise Increases sputum production Bilton, D, etal. Thorax 44:859, 1989

42 Insufflation-Exsufflation Stimulates cough with + and pressure Bach JR, Chest 105:1538, 1994

43 Positive Airway Pressure PEP Pursed lip breathing More effective than IS or IPPB Ricksten, SE, etal. Chest 89:774, 1986

44 Oscillation of the Airway Flutter Little research done 3 times more sputum in CF than cough or PD Konstan MW, etal. J Pediatr 124:689, 1994 Not confirmed or effective Homnick DN, etal. Chest 114:993, 1998 App EM, etal. Chest 114:171, 1998 Acapella Lung Flute Effective for sputum sampling Quake Generates vibrations on inhalation and exhalation

45 Lung Flute

46 Chest Wall Oscillation Vest Effective in CF Kluf J, etal. Pediatr Pulmonol 22:271, 1996 Not established in non-cf patients

47 HFCWO

48 Summary Difference between Mucus and Sputum Sputum becomes more viscid Mild does not thicken secretions A number of different solution available CPT is a gold standard Use exercise NAC does not work on pulmonary sputum Pulmozyme is only used for CF

49 Questions, Comments, Happy Thoughts?

Chapter 9. Mucus-controlling Drug Therapy. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Chapter 9. Mucus-controlling Drug Therapy. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 9 Mucus-controlling Drug Therapy Drug Control of Mucus: A Perspective Mucociliary escalator is a major defense system Failure may result in mechanical obstruction of the airway Properties of mucus

More information

Disclaimer. Objectives. I can t cough it up! Airway Clearance Therapy. Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist

Disclaimer. Objectives. I can t cough it up! Airway Clearance Therapy. Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist I can t cough it up! Airway Clearance Therapy Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist 1 Disclaimer Name of presenter: Heather Murgatroyd, BA, RRT, RPSGT Name of employer: RespirTech I

More information

The Acute & Maintenance Treatment of Asthma via Aerosolized Medications

The Acute & Maintenance Treatment of Asthma via Aerosolized Medications The Acute & Maintenance Treatment of Asthma via Aerosolized Medications Douglas S. Gardenhire, EdD, RRT-NPS, FAARC Associate Professor and Chairman Department of Respiratory Therapy Objectives Define Asthma.

More information

Terminology. Terminology. Terminology. Mucus in Disease States. Mucus in Disease States. RSPT 2317 Mucoactive agents. RSPT 2217 Mucoactive Agents

Terminology. Terminology. Terminology. Mucus in Disease States. Mucus in Disease States. RSPT 2317 Mucoactive agents. RSPT 2217 Mucoactive Agents Terminology RSPT 2217 Mucoactive Agents Gardenhire Chapter 9 Mucus secretion from mucous membranes, including surface goblet cells and submucosal glands Sputum expectorated secretions that contain respiratory

More information

National Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008

National Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008 Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis April 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not

More information

CYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions

CYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions CYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions Issue 1: Hypertonic Saline Summary: Preserving lung function is a crucial element in the care of the individual with

More information

The pharmacologic approach to airway clearance: Mucoactive agents

The pharmacologic approach to airway clearance: Mucoactive agents Rubin. Mucoactive medications. Page # 1 The pharmacologic approach to airway clearance: Mucoactive agents Bruce K. Rubin, MEngr, MD, MBA, FRCPC Professor and Vice-Chair of Pediatrics Professor of Biomedical

More information

Bronchiectasis. Grant Waterer. Professor of Medicine, University of Western Australia Adjunct Professor of Medicine, Northwestern University, Chicago

Bronchiectasis. Grant Waterer. Professor of Medicine, University of Western Australia Adjunct Professor of Medicine, Northwestern University, Chicago Bronchiectasis Grant Waterer MBBS PhD MBA FRACP FCCP Professor of Medicine, University of Western Australia Adjunct Professor of Medicine, Northwestern University, Chicago Conflicts of Interest I have

More information

4.6 Small airways disease

4.6 Small airways disease 4.6 Small airways disease Author: Jean-Marc Fellrath 1. INTRODUCTION Small airways are defined as any non alveolated and noncartilaginous airway that has an internal diameter of 2 mm. Several observations

More information

Overview of Cystic fibrosis in children. Apeksha Sathyaprasad, MD Pediatric pulmonologist

Overview of Cystic fibrosis in children. Apeksha Sathyaprasad, MD Pediatric pulmonologist Overview of Cystic fibrosis in children Apeksha Sathyaprasad, MD Pediatric pulmonologist No conflicts of interest OBJECTIVES Review pathophysiology of pulmonary disease in cystic fibrosis Review diagnostic

More information

Worth Its SALT? Hypertonic Saline Revisited

Worth Its SALT? Hypertonic Saline Revisited Worth Its SALT? Hypertonic Saline Revisited 1 NYC Long Island Michael McPeck, RRT FAARC Aerosol Research Scientist Aerosol Laboratory Division of Pulmonary, Critical Care & Sleep Medicine State University

More information

Chronic Obstructive Pulmonary Disease (COPD) Copyright 2014 by Mosby, an imprint of Elsevier Inc.

Chronic Obstructive Pulmonary Disease (COPD) Copyright 2014 by Mosby, an imprint of Elsevier Inc. Chronic Obstructive Pulmonary Disease () 8.18.18 Copyright 2014 by Mosby, an imprint of Elsevier Inc. Description Airflow limitation not fully reversible progressive Abnormal inflammatory response of lungs

More information

The objectives of this presentation are to

The objectives of this presentation are to 1 The objectives of this presentation are to 1. Review the mechanics of airway clearance 2. Understand the difference between secretion mobilization and secretion clearance 3. Identify conditions that

More information

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS Cystic Fibrosis Jennifer McDaniel, BS, RRT-NPS Overview Cystic fibrosis is the most common fatal, inherited disease in the U. S. CF results from a defective autosomal recessive gene One copy of gene =

More information

Dean R Hess PhD RRT FAARC

Dean R Hess PhD RRT FAARC Conference Summary Airway Clearance: Physiology, Pharmacology, Techniques, and Practice Dean R Hess PhD RRT FAARC Introduction Physiology Pharmacology Techniques Practice What to Do? Summary Clinicians

More information

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF What is Cystic Fibrosis? CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Chronic, progressive and life limiting autosomal recessive genetic disease characterized by chronic

More information

A Place For Airway Clearance Therapy In Today s Healthcare Environment

A Place For Airway Clearance Therapy In Today s Healthcare Environment A Place For Airway Clearance Therapy In Today s Healthcare Environment Michigan Society for Respiratory Care 2015 Fall Conference K. James Ehlen, MD October 6, 2015 Objectives Describe patients who will

More information

Pulmo-Park Pom-Pom Shooter: Measuring the Effect of Restricted Breathing on Peak Expiratory Flow (PEF) Student Information Page Activity 5D

Pulmo-Park Pom-Pom Shooter: Measuring the Effect of Restricted Breathing on Peak Expiratory Flow (PEF) Student Information Page Activity 5D Pom-Pom Shooter: Measuring the Effect of Restricted Breathing on Peak Expiratory Flow (PEF) Student Information Page Activity 5D Students with asthma or other respiratory problems should not perform the

More information

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline Systems Pharmacology 3320 2017 Respiratory Pharmacology Associate Professor Peter Henry (Rm 1.34) Peter.Henry@uwa.edu.au Division of Pharmacology, School of Biomedical Sciences Lecture series : General

More information

Bronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs.

Bronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs. Bronchitis Introduction Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to the lungs. It causes shortness of breath, wheezing and chest tightness as well as a cough that

More information

Focus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis

Focus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis Focus on (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Autosomal recessive, multisystem

More information

Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review

Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review Nila A Sathe MA MLIS, Shanthi Krishnaswami MBBS MPH, Jeff Andrews MD, Cathy Ficzere PharmD BCPS, and Melissa

More information

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association MEDICAL POLICY SUBJECT: AIRWAY CLEARANCE DEVICES: OSCILLATORY DEVICES (e.g. High frequency MECHANICAL PERCUSSORS AND ASSISTED 04/15/04, 04/21/05, 02/16/05, PAGE: 1 OF: 8 If a product excludes coverage

More information

an inflammation of the bronchial tubes

an inflammation of the bronchial tubes BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious

More information

PomPom SHOOTER. Activity Background: Common Obstructive Lung Disorders:

PomPom SHOOTER. Activity Background: Common Obstructive Lung Disorders: CAUTION: Students with asthma or other respiratory problems should NOT perform the breathing exercises in this activity because they involve repeated maximal inhalations and exhalations and use of a breathing

More information

Protocol. Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

Protocol. Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions Oscillatory Devices for the Treatment of Cystic Fibrosis and Other (10115) Medical Benefit Effective Date: 01/01/18 Next Review Date: 07/18 Preauthorization No Review Dates: 01/07, 03/08, 03/09, 03/10,

More information

Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy

Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy What is Cystic Fibrosis? Chronic, progressive

More information

PATHOPHYSIOLOGICAL PROCESS TEMPLATE

PATHOPHYSIOLOGICAL PROCESS TEMPLATE 1 PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Chronic obstructive pulmonary disease (COPD) DEFINITION: COPD can be defined as a disease in which there is a significant damage to the lungs thus reducing

More information

Cystic Fibrosis the future

Cystic Fibrosis the future Cystic Fibrosis the future Pathophysiologic cascade Abnormal Gene Abnormal CFTR Therapy Gene replacement Protein replacement Gene read through therapy Abnormal sodium chloride & water movement through

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease By: Dr. Fatima Makee AL-Hakak () University of kerbala College of nursing Out lines What is the? Overview Causes of Symptoms of What's the difference between and asthma?

More information

Non Cystic Fibrosis Bronchiectasis: How to Proceed?

Non Cystic Fibrosis Bronchiectasis: How to Proceed? Non Cystic Fibrosis Bronchiectasis: How to Proceed? Dr Ankit Parakh MD, DNB, MNAMS, RCPCH Fellow (UK), European Diplomate of Pediatric Respiratory Medicine ERS Fellowship Pediatric Medicine & NIV (GOSH,

More information

RESPIRATORY REHABILITATION

RESPIRATORY REHABILITATION RESPIRATORY REHABILITATION By: Dr. Fatima Makee AL-Hakak University of kerbala College of nursing CHEST PHYSIOTHERAPY Chest physiotherapy (CPT) includes: 1.Postural drainage. 2.Chest percussion and vibration.

More information

Section: Durable Medical Equipment Last Reviewed Date: June Policy No: 45 Effective Date: September 1, 2014

Section: Durable Medical Equipment Last Reviewed Date: June Policy No: 45 Effective Date: September 1, 2014 Medical Policy Manual Topic: Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Disorders Date of Origin: May 26, 2011 Section: Durable Medical Equipment Last Reviewed Date:

More information

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza) Bronchiectasis What is Bronchiectasis? Bronchiectasis (pronounced bron-kee-ek'-tas-is) is a condition of the airways in the lungs. These airways (bronchial tubes) are tubelike structures that branch from

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: October 15, 2018 Related Policies: None Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Description Oscillatory devices are alternatives to

More information

COPD. Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS

COPD. Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS IN THE NAME OF GOD COPD Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS Definition of COPD* COPD is a preventable and treatable chronic lung disease characterized by airflow limitation that is not fully

More information

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary

More information

Levine Children s Hospital. at Carolinas Medical Center. Respiratory Care Department

Levine Children s Hospital. at Carolinas Medical Center. Respiratory Care Department Page 1 of 7 at Carolinas Medical Center 02.04 Pediatric Patient-Centered Respiratory Care Protocol Application of Chest Physical Therapy Created: 1/98 Reviewed: 4/03, 1/05, 6/08 Revised: Purpose: To describe

More information

Chapter 10 Respiration

Chapter 10 Respiration 1 Chapter 10 Respiration Introduction/Importance of the Respiratory System All eukaryotic organisms need oxygen to perform cellular respiration (production of ATP), either aerobically or anaerobically.

More information

Bronchiectasis. Introduction. Key points

Bronchiectasis. Introduction. Key points 15 Bronchiectasis Introduction i Key points Patients with bronchiectasis typically have chronic airway infection, punctuated by acute exacerbations and accompanied by progressive airflow obstruction. Bronchiectasis

More information

Chronic obstructive lung disease. Dr/Rehab F.Gwada

Chronic obstructive lung disease. Dr/Rehab F.Gwada Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem

More information

Cystic fibrosis: From childhood to adulthood. Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel

Cystic fibrosis: From childhood to adulthood. Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel Cystic fibrosis: From childhood to adulthood Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel Vas deference H 2 O Cl - Na + H 2 O Na + Cl - Cl - Cl -

More information

Pharmacological airway clearance strategies in bronchiectasis

Pharmacological airway clearance strategies in bronchiectasis Chapter 16 Pharmacological airway clearance strategies in bronchiectasis P.T. Bye*,#,", E.M.T. Lau*,#," and M.R. Elkins*," Summary Impaired mucociliary clearance and mucus retention contribute to the chronic

More information

Lecture Notes. Chapter 3: Asthma

Lecture Notes. Chapter 3: Asthma Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features

More information

Integrated Cardiopulmonary Pharmacology Third Edition

Integrated Cardiopulmonary Pharmacology Third Edition Integrated Cardiopulmonary Pharmacology Third Edition Chapter 13 Pharmacologic Management of Asthma, Chronic Bronchitis, and Emphysema Multimedia Directory Slide 7 Slide 12 Slide 60 COPD Video Passive

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Oscillatory Devices for the Treatment of Respiratory Conditions File Name: Origination: Last CAP Review: Next CAP Review: Last Review: oscillatory_devices_for_treatment_of_respiratory_conditions

More information

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. Asthma Air Flow Limitation In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. True whether reversible, asthma and exercise-induced bronchospasm,

More information

Respiratory Pharmacology: Treatment of Cystic Fibrosis

Respiratory Pharmacology: Treatment of Cystic Fibrosis Respiratory Pharmacology: Treatment of Cystic Fibrosis Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart

More information

COPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES

COPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES COPD C - Chronic O - Obstructive P - Pulmonary D - Disease 1 OBJECTIVES Following this presentation the participant should be able to demonstrate understanding of chronic lung disease by successful completion

More information

COPD. Breathing Made Easier

COPD. Breathing Made Easier COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought

More information

COPD: Change in Definition. COPD Pathology with 3D Interactive. COPD: Definitions of 21st Century 1. COPD Includes Chronic Bronchitis 2

COPD: Change in Definition. COPD Pathology with 3D Interactive. COPD: Definitions of 21st Century 1. COPD Includes Chronic Bronchitis 2 COPD: Change in Definition COPD Pathology with 3D Interactive by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org COPD used to include 5 disease processes 1 1 Chronic Bronchitis 2 Emphysema

More information

RESPIRATORY DISORDERS

RESPIRATORY DISORDERS RESPIRATORY DISORDERS INTRODUCTION Respiratory disorders refers to the medical term that include different pathological conditions affecting the organs and tissues of respiratory system which make gas

More information

Pulmonary Exacerbations:

Pulmonary Exacerbations: Pulmonary Exacerbations: Better Understanding Needed Michael Tracy, MD Clinical Assistant Professor Pediatric Pulmonary CF Pulmonary Exacerbations Definition Importance Causes Treatment Research opportunities

More information

Respiratory Anesthetic Emergencies in Oral and Maxillofacial Surgery. By: Lillian Han

Respiratory Anesthetic Emergencies in Oral and Maxillofacial Surgery. By: Lillian Han Respiratory Anesthetic Emergencies in Oral and Maxillofacial Surgery By: Lillian Han Background: Respiratory anesthetic emergencies are the most common complications during the administration of anesthesia

More information

COPD and Asthma: Similarities and differences Prof. Peter Barnes

COPD and Asthma: Similarities and differences Prof. Peter Barnes and Asthma: Similarities and Differences and Asthma: 1 Imperial College Peter Barnes FRS, FMedSci, National Heart & Lung Institute Imperial College, London, UK p.j.barnes@imperial.ac.uk Royal Brompton

More information

BY BILL PRUITT, RRT, AE-C, CPFT, MBA, AND MICHAEL JACOBS, RN, CCRN, CEN, MSN

BY BILL PRUITT, RRT, AE-C, CPFT, MBA, AND MICHAEL JACOBS, RN, CCRN, CEN, MSN C E 2.5 ANCC/AACN CONTACT HOURS Clearing away pulmonary secretions Excess or retained pulmonary secretions impair ventilation, invite infection, and may threaten survival. Find out who s at greatest risk

More information

Over the last several years various national and

Over the last several years various national and Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American

More information

Chapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Chapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators Clinical Indications for Use Indication for anticholinergic bronchodilator COPD maintenance Indication for combined anticholinergic and β-agonist

More information

Role of mucolytics in the management of COPD

Role of mucolytics in the management of COPD REVIEW Role of mucolytics in the management of COPD Phillippa J Poole University of Auckland, Auckland, New Zealand Abstract: There is, to date, no medical therapy that modifies the decline in lung function

More information

Treatment of Cough. Cough is a useful protective reflex. Cough is an indicator of an underlying illness.

Treatment of Cough. Cough is a useful protective reflex. Cough is an indicator of an underlying illness. Treatment of Cough Cough is a useful protective reflex. Cough is an indicator of an underlying illness. Mechanical stimulation of large respiratory passages, OR: Chemical stimulation of alveoli. After

More information

Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England: 16029/P NHS England INFORMATION READER BOX Directorate Medical Operations and

More information

Chronic respiratory disease: towards better treatments

Chronic respiratory disease: towards better treatments Chronic respiratory disease: towards better treatments Alaina J. Ammit PhD Alaina.Ammit@uts.edu.au Professor of Respiratory Pharmacology, UTS Director, Woolcock Emphysema Centre, Woolcock Institute of

More information

Treatment of Cough. Cough is a useful protective reflex. Cough is an indicator of an underlying illness.

Treatment of Cough. Cough is a useful protective reflex. Cough is an indicator of an underlying illness. Treatment of Cough Cough is a useful protective reflex. Cough is an indicator of an underlying illness. Mechanical stimulation of large respiratory passages, OR: Chemical stimulation of alveoli. After

More information

Aerosol Therapy. Aerosol Therapy. RSPT 1410 Humidity & Aerosol Therapy Part 4

Aerosol Therapy. Aerosol Therapy. RSPT 1410 Humidity & Aerosol Therapy Part 4 1 RSPT 1410 Humidity & Part 4 Wilkins Chapter 36; p. 801-806 2 Stability: the tendency for aerosol particles to remain in Size: the the particle, the greater the tendency toward stability the the particle,

More information

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test? Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard

More information

acapella vibratory PEP Therapy System Maximizing Therapy Effectiveness, Empowering Patient Compliance

acapella vibratory PEP Therapy System Maximizing Therapy Effectiveness, Empowering Patient Compliance acapella vibratory PEP Therapy System Maximizing Therapy Effectiveness, Empowering Patient Compliance Investigating Questions Each acapella vibratory PEP therapy system uniquely provides PEP therapy by

More information

Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis

Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Eur Respir J 2002; 20: 122 126 DOI: 10.1183/09031936.02.00264002 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Bronchial reactions to the

More information

High Frequency Chest Wall Oscillation Devices

High Frequency Chest Wall Oscillation Devices High Frequency Chest Wall Oscillation Devices Policy Number: Original Effective Date: MM.01.007 07/15/2003 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 10/24/2014 Section: DME

More information

Respiratory Management- Your Questions Answered! Michelle Chatwin, PhD Consultant Physiotherapist

Respiratory Management- Your Questions Answered! Michelle Chatwin, PhD Consultant Physiotherapist Respiratory Management- Your Questions Answered! Michelle Chatwin, PhD Consultant Physiotherapist Why Are People Affected Differently Neuromuscular Disease; A Spectrum Its severity varies widely within

More information

Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England E03X05/01 Information Reader Box (IRB) to be inserted on inside

More information

Citation for published version (APA): Schans, C. P. V. D. (1991). Physiotherapy and bronchial mucus transport s.n.

Citation for published version (APA): Schans, C. P. V. D. (1991). Physiotherapy and bronchial mucus transport s.n. University of Groningen Physiotherapy and bronchial mucus transport van der Schans, Cees P. IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air

Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air through the airways. As asthma, COPD ( chronic bronchitis

More information

High Frequency Chest Wall Oscillating Devices (HFCWO) (Airway Clearance Systems)

High Frequency Chest Wall Oscillating Devices (HFCWO) (Airway Clearance Systems) High Frequency Chest Wall Oscillating Devices (HFCWO) (Airway Clearance Systems) Date of Origin: 05/2015 Last Review Date: 07/26/2017 Effective Date: 07/26/2017 Dates Reviewed: 07/2016 Developed By: Medical

More information

The Use of Active Cycle of Breathing Technique (ACBT) In Pulmonary Physiotherapy: A Critical Review of the Literature Lauro G. Villegas Jr.

The Use of Active Cycle of Breathing Technique (ACBT) In Pulmonary Physiotherapy: A Critical Review of the Literature Lauro G. Villegas Jr. The Use of Active Cycle of Breathing Technique (ACBT) In Pulmonary Physiotherapy: A Critical Review of the Literature Lauro G. Villegas Jr., PTRP Keywords: Active Cycle of Breathing Technique (ACBT), Pulmonary

More information

Effect of N-Acetylcysteine on Air Trapping in COPD. A Randomized Placebo-Controlled Study

Effect of N-Acetylcysteine on Air Trapping in COPD. A Randomized Placebo-Controlled Study CHEST Effect of N-Acetylcysteine on Air Trapping in COPD A Randomized Placebo-Controlled Study David Stav, MD; and Meir Raz, MD Original Research COPD Background: FEV 1 is used for the classification of

More information

Comparison of inhaled mannitol, daily rhdnase, and a combination. of both in children with cystic fibrosis: a randomised trial

Comparison of inhaled mannitol, daily rhdnase, and a combination. of both in children with cystic fibrosis: a randomised trial Thorax Online First, published on December 8, 2009 as 10.1136/thx.2009.116970 Comparison of inhaled mannitol, daily rhdnase, and a combination of both in children with cystic fibrosis: a randomised trial

More information

Function of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)

Function of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration) Function of the Respiratory System Exchange CO2 (on expiration) for O2 (on inspiration) Upper Respiratory Tract Includes: Nose Mouth Pharynx Larynx Function: Warms and humidifies the inspired air Filters

More information

Mucolytics in cystic fibrosis

Mucolytics in cystic fibrosis PAEDIATRIC RESPIRATORY REVIEWS (2007) 8, 24 29 MINI-SYMPOSIUM: AIRWAY CLEARANCE IN CYSTIC FIBROSIS Mucolytics in cystic fibrosis Markus O. Henke 1 and Felix Ratjen 2, * 1 Department of Pulmonary Medicine,

More information

Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection)

Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection) Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection) DESCRIPTION Mucomist Respirator Solution is a derivative of the amino acid, cysteine. It acts mostly

More information

10/05/2017. Learning Objectives. Etiology and Prevalence. Diagnosis of Cystic Fibrosis. Disease of Childhood? Survival in Cystic Fibrosis

10/05/2017. Learning Objectives. Etiology and Prevalence. Diagnosis of Cystic Fibrosis. Disease of Childhood? Survival in Cystic Fibrosis Management of the Cystic Fibrosis Patient Jessica Goggin, MAS, RN Nurse Manager UC San Diego Adult Cystic Fibrosis Program Learning Objectives 1. Describe the symptoms associated with Cystic Fibrosis (CF).

More information

TITLE: Hypertonic Saline Nebules for Patients with Cystic Fibrosis and Bronchioectasis: A Review of the Clinical and Cost-Effectiveness

TITLE: Hypertonic Saline Nebules for Patients with Cystic Fibrosis and Bronchioectasis: A Review of the Clinical and Cost-Effectiveness TITLE: Hypertonic Saline Nebules for Patients with Cystic Fibrosis and Bronchioectasis: A Review of the Clinical and Cost-Effectiveness DATE: 16 March 2009 CONTEXT AND POLICY ISSUES: Hypertonic saline

More information

Cystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina

Cystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina Cystic Fibrosis: Progress in Treatment Management Patrick A. Flume, M.D. Medical University of South Carolina Disclosures Grant support Mpex Pharmaceuticals, Inc Gilead Sciences, Inc Bayer Healthcare AG

More information

Supplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus

Supplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Supplementary Medications during asthma attack Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Conflicts of Interest None Definition of Asthma Airway narrowing that is

More information

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE RHYS JEFFERIES ARTP education Learning Objectives Examine the clinical features of airways disease to distinguish

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Wed, 31 Oct 2018 11:13:48 GMT) CTRI Number Last Modified On 17/01/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Respiratory Therapy. Medical/Scientific/General Background

Respiratory Therapy. Medical/Scientific/General Background Respiratory Therapy Medical/Scientific/General Background Marketing Europe Dr. Rainer Jakobs PMM Europe 1 Dr. Rainer Jakobs, PMM Europe RT Medical/Scientific/General Background 2 Dr. Rainer Jakobs, PMM

More information

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE CYSTIC FIBROSIS Madhu Pendurthi MD MPH Staff Physician, Mercy Hospital Springfield, MO NO CONFLICT OF INTEREST TO DISCLOSE OBJECTIVES Epidemiology of Cystic Fibrosis (CF) Genetic basis and pathophysiology

More information

Physiotherapy in lung disease - top tips for clinicians. Sita Kansagra Specialist Outpatient Physiotherapist

Physiotherapy in lung disease - top tips for clinicians. Sita Kansagra Specialist Outpatient Physiotherapist Physiotherapy in lung disease - top tips for clinicians Sita Kansagra Specialist Outpatient Physiotherapist Aims: Run through current physiotherapy practice Airway clearance Pulmonary rehabilitation Dysfunctional

More information

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis (Review)

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis (Review) Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis (Review) Nash EF, Stephenson A, Ratjen F, Tullis E This is a reprint of a Cochrane review, prepared and maintained by The Cochrane

More information

CHAPTER 7.1 STRUCTURES OF THE RESPIRATORY SYSTEM

CHAPTER 7.1 STRUCTURES OF THE RESPIRATORY SYSTEM CHAPTER 7.1 STRUCTURES OF THE RESPIRATORY SYSTEM Pages 244-247 DO NOW What structures, do you think, are active participating in the breathing process? 2 WHAT ARE WE DOING IN TODAY S CLASS Finishing Digestion

More information

Lecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)

Lecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features

More information

High Frequency Chest Wall Oscillation Devices

High Frequency Chest Wall Oscillation Devices High Frequency Chest Wall Oscillation Devices Policy Number: Original Effective Date: MM.01.007 07/15/2003 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/18/2015 Section: DME

More information

Active Cycle of Breathing Technique

Active Cycle of Breathing Technique Active Cycle of Breathing Technique Full Title of Guideline: Author (include email and role): Division & Speciality: Version: 3 Ratified by: Scope (Target audience, state if Trust wide): Review date (when

More information

Acapella versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial

Acapella versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial Chronic Respiratory Disease 2007; 4: 67 74 http://crd.sagepub.com ORIGINAL PAPER Acapella versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial JE Patterson,

More information

Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions Policy Number: 1.01.15 Last Review: 3/2018 Origination: 3/2001 Next Review: 3/2019 Policy Blue Cross and Blue Shield

More information

Hyperinflation Therapy and the Tools to Accomplish It!! Bill Barnes, RN, RRT Good Shepherd Rehabilitation Network

Hyperinflation Therapy and the Tools to Accomplish It!! Bill Barnes, RN, RRT Good Shepherd Rehabilitation Network Hyperinflation Therapy and the Tools to Accomplish It!! Bill Barnes, RN, RRT Good Shepherd Rehabilitation Network HYPERINFLATION THERAPY Challenges in Post Acute Care Deconditioning Malnutrition Hydration

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ORAL MUCOLYTICS Ref ID: 2511 Bachh AA, Shah NN, Bhargava R et al. Effect oral N- in COPD - A randomised controlled trial. JK Practitioner. 2007; 14(1):12-16. Ref ID: 2511 RCT Single blind; unclear allocation

More information

Non-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX

Non-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX Non-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX Pioneer of Respiratory Medicine 2016 marked 200th anniversary of his

More information

DISEASES OF THE RESPIRATORY SYSTEM 2018 DR HEYAM AWAD LECTURE 3: CHRONIC BRNCHITIS AND BRONCHIECTASIS

DISEASES OF THE RESPIRATORY SYSTEM 2018 DR HEYAM AWAD LECTURE 3: CHRONIC BRNCHITIS AND BRONCHIECTASIS DISEASES OF THE RESPIRATORY SYSTEM 2018 DR HEYAM AWAD LECTURE 3: CHRONIC BRNCHITIS AND BRONCHIECTASIS INTRDUCTION In the last lecture we discussed the difference between restrictive and obstructive lung

More information